Background The long‐term results of web‐based behavioural intervention in non‐alcoholic
fatty liver disease (NAFLD) have not been described in patients followed in specialised …

Background The current management of metabolic dysfunction‐associated steatotic liver
disease (MASLD) relies on lifestyle intervention. Prior studies have shown that nutritional …

Simple Summary Non-alcoholic fatty liver disease (NAFLD) has become a significant public
health concern, affecting over 30% of the population. The incidence of NAFLD-related …

Background & Aims Long-term studies of the prognosis of NAFLD are scarce. Here, we
investigated the risk of major adverse liver outcomes (MALO) in a large cohort of patients …

The metabolic dysfunction that characterizes obesity and type 2 diabetes mellitus affects not
only the heart and kidneys, but also the liver. Although lifestyle modification remains the …

Standards of care summarized in clinical practice guidelines for nonalcoholic fatty liver
disease (NAFLD) offer clinicians a streamlined diagnostic and management approach …

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as
nonalcoholic fatty liver disease (NAFLD), is the most common liver disease. It has a rapidly …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

Abstract Introduction and Objectives Data on the prevalence of non-alcoholic fatty liver
disease (NAFLD) in subgroups of the United States (US) population are limited. This study …

Background: There are limited data on the progression of liver stiffness measurement (LSM)
by vibration-controlled transient elastography (VCTE) in people with type 2 diabetes (T2DM) …